We've just published our insights and takeaways from the 2024 SCOPE Summit on our website. Our latest blog post explores the evolving landscape of decentralized trials, the hurdles of direct-to-patient shipments, and underscores the growing importance of sustainability as a strategic priority. Discover how Artyc is not only adapting to industry shifts but is at the forefront of driving clinical trials towards greater efficiency, enhanced patient focus, and sustainability. ð Read the full post here https://lnkd.in/grcHt8Ri #clinicaltrials #scope2024 #scopesummit #decentralizedtrials
Artycâs Post
More Relevant Posts
-
Join TriNetX for an upcoming webinar on June 3rd at noon ET! Discover how diverse representation transforms patient outcomes through better trial design. https://ow.ly/zGN330sCcAW #DiversityinClinicalTrials #RealWorldData
To view or add a comment, sign in
-
Join TriNetX for an upcoming webinar on June 3rd at noon ET! Discover how increasing diverse representation transforms patient outcomes through better trial design. https://ow.ly/hOz130sCqjX #DiversityinClinicalTrials #RealWorldData
To view or add a comment, sign in
-
Help Shape the Future of Remote Patient Monitoring: Participate in Pulsli's Survey! Pulsli is excited to launch its survey investigating product-market fit and showcasing our groundbreaking innovation in Remote Patient Monitoring. We invite all medical professionals to participate and provide feedback, guiding our future product design and prioritization. Watch our video to learn more and take part in shaping the future of healthcare. Your insights are invaluable! #DrGPT
Pulsli is excited to launch it's survey investigating product market fit and showcasing our ground breaking innovation in Remote Patient Monitoring. We invite all medical professionals to participate in our survey and provide their feedback to guide future product design and prioritization. https://lnkd.in/gtKx3fk5 Also make sure to check the personal invite by our CMO, Andrew J. Sauer, MD and Harvey Castro, MD, MBA.: https://lnkd.in/gv8MGyQc Andrew J. Sauer, MD, Harvey Castro, MD, MBA., Ioannis Mastoris, MD, FACC,Boris Krajacic, MD, MSc , Connie Lewis, Tina Ivovic, Vlad Zah, Reuben Lawson, Karen Friedrichs, Catherine Kingsford, GAICD, Sasha Banjac, Rok Ursic
To view or add a comment, sign in
-
Join TriNetX for an upcoming webinar on June 3rd at noon ET! Discover how diverse representation transforms patient outcomes through better trial design. https://ow.ly/2GRW30sCLq9 #DiversityinClinicalTrials #RealWorldData
To view or add a comment, sign in
-
I am pleased to share Lifebit's latest blog post on the importance of Real World Data and Evidence (RWD/RWE) in advancing clinical research and trials. In this blog, we explore how RWD can enhance generalizability, accelerate approval timelines, and maximize cost efficiency. By addressing challenges such as data quality and interoperability, we can streamline healthcare research and pave the way for data-driven healthcare innovation. For the full blog: https://bit.ly/3Vf8G92 #HealthcareResearch #RWD #RWE #Innovation #Lifebit
The benefits of leveraging real world data and evidence in clinical research and trials
To view or add a comment, sign in
-
Check out Lifebit's latest blog that delves into the transformative potential of Real World Data and Evidence (RWD/RWE) in clinical research and trials. As we navigate the complexities of leveraging RWD, we uncover its ability to drive innovation, improve patient outcomes, and revolutionize healthcare research methodologies. Join Lifebit in exploring how RWD is reshaping the landscape of clinical trials and propelling us towards a future of data-driven healthcare. Read more here: https://bit.ly/4abP7CK #HealthcareInnovation #RWD #RWE #DataScience #Lifebit
The benefits of leveraging real world data and evidence in clinical research and trials
To view or add a comment, sign in
-
Join TriNetX for an upcoming webinar on June 3rd! Learn how diverse representation transforms patient outcomes through better trial design. Register: https://bit.ly/44E92c4 #DiversityinClinicalTrials #RealWorldData
To view or add a comment, sign in
-
Empowering Providers and Patients with Easy To Use Molecular Testing As we celebrate Patient Experience Week, 3EO Health is proud to emphasize the transformative power of #EaseOfUse in our molecular testing solutions. Our goal is to make molecular testing as straightforward and non-intrusive as possible, enhancing both patient and provider experience. Our easier-than-easy molecular testing platform provides: Patient Comfort: Our proprietary swab is designed to minimize discomfort, making the diagnostic process less daunting for patients. 12 Seconds of Hands On Time: By simplifying the steps to test, we decrease workflow burden, freeing up critical minutes to improve patient care. No Specialized Training: Our intuitive workflow requires no specialized training, allowing any team member on staff to confidently utilize our tests, enhancing overall efficiency. We understand that the simpler the process, the more profound its impact. We are committed to innovating accessible solutions that support clinicians in delivering top-notch care. #PatientExperienceWeek #MolecularTesting #MakingMolecularMatter #AccessibilityForAll #AffordabilityNotCompromise
To view or add a comment, sign in
-
Delighted to share this study led by @Inka Ristow, @Markus Sauer and their dedicated team at @UKE Hamburg! Their research underscores how software-assisted assessments, like #mintLesionâ¢, help improve oncological patient care by elevating iRECIST-guided CT scan evaluations.  Benefits of using #mintLesionâ¢? ð Expedited reading times ð Fewer errors ð¤ Improved inter-reader agreement  These findings emphasize the critical role of technology in optimizing oncological response evaluation.  Want to read more about the study? Follow this link: https://bit.ly/3vvhQ6T  #OncologyResearch #iRECIST #HealthcareInnovation #StructuredReporting
To view or add a comment, sign in
-
Last week, I moderated the panel, âContinued Growth of Decentralized Testing: Fact or Fiction?â at AdvaMedâs the MedTech Conference alongside Valerie Dixon, Vasu Nadella, and April Veoukas. We discussed the drivers and barriers to point of care (POC) testing including what it takes to sustain growth across professional and patient settings and to maintain a competitive edge in the market. Thanks to all who watched this session. Reach out if you are curious to learn more about our discussion. #MedTechCon #Diagnostics #POC
To view or add a comment, sign in
1,904 followers